Green tea extract may boost fertility in women with fibroids

NCT ID NCT05364008

Ongoing Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a low-caffeine green tea extract (EGCG) can shrink uterine fibroids and improve pregnancy and live birth rates in women aged 18-40 who have been trying to conceive for at least six months. Participants take the extract and are monitored for changes in fibroid size and pregnancy outcomes. The goal is to see if this natural compound offers a non-surgical option to improve fertility.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEIOMYOMA, UTERINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder leiomyoma uterine corpus leiomyoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEIOMYOMA, UTERINE

Contacts and locations

Locations

Johns Hopkins, Division of Reproductive Science and Women's Health Research

Baltimore, Maryland, 21205, United States
University of Chicago, Department of Obstetrics and Gynecology

Chicago, Illinois, 60637, United States
University of Illinois at Chicago College of Medicine

Chicago, Illinois, 60612, United States
Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.